Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Total 13F shares
-
92,755,820
-
Share change
-
+10,131,720
-
Total reported value
-
$292,205,234
-
Put/Call ratio
-
44%
-
Price per share
-
$3.15
-
Number of holders
-
173
-
Value change
-
+$33,009,582
-
Number of buys
-
91
-
Number of sells
-
51
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q4 2024
As of 31 Dec 2024,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,755,820 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, Qube Research & Technologies Ltd, PNC Financial Services Group, Inc., MARSHALL WACE, LLP, STATE STREET CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
174
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.